132 related articles for article (PubMed ID: 6210596)
21. Disordered immunoregulatory functions in patients with chronic active hepatitis.
Nonomura A; Tanino M; Kurumaya H; Ohta G; Kato Y; Kobayashi K
Clin Exp Immunol; 1982 Mar; 47(3):595-605. PubMed ID: 6211306
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease.
Asquith P; Kraft SC; Rothberg RM
Gastroenterology; 1973 Jul; 65(1):1-7. PubMed ID: 4720822
[No Abstract] [Full Text] [Related]
23. Suppressor T cells in systemic lupus erythematosus: lack of defective in vitro suppressor cell generation in patients with active disease.
Tsokos GC; Balow JE
J Clin Lab Immunol; 1982 Jun; 8(2):83-90. PubMed ID: 6213778
[No Abstract] [Full Text] [Related]
24. Immunoglobulin M memory B cell decrease in inflammatory bowel disease.
Di Sabatino A; Carsetti R; Rosado MM; Ciccocioppo R; Cazzola P; Morera R; Tinozzi FP; Tinozzi S; Corazza GR
Eur Rev Med Pharmacol Sci; 2004; 8(5):199-203. PubMed ID: 15638230
[TBL] [Abstract][Full Text] [Related]
25. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
Victorino RM
J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
[TBL] [Abstract][Full Text] [Related]
26. Defective suppressor cell activity in essential mixed cryoglobulinemia.
Meroni PL; Barcellini W; Messina C; De Bartolo G; Capsoni F; Invernizzi F
J Clin Lab Immunol; 1982 Sep; 8(3):177-82. PubMed ID: 6215490
[TBL] [Abstract][Full Text] [Related]
27. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease.
Brown TE; Bankhurst AD; Strickland RG
J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936
[TBL] [Abstract][Full Text] [Related]
28. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
29. [Autologous mixed lymphocyte culture (AMLC)].
Volk HD; Grunow R
Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
[TBL] [Abstract][Full Text] [Related]
30. Concanavalin A induced suppression of lymphocyte proliferation in chronic liver disease. A study of suppressor and responder populations in autologous and allogeneic systems.
Arabi MA; Nouri-Aria KT; Alexander GJ; Eddleston AL; Williams R
J Clin Lab Immunol; 1985 Dec; 18(4):161-5. PubMed ID: 2937919
[TBL] [Abstract][Full Text] [Related]
31. A prospective, blind investigation of immunological reactions in chronic inflammatory bowel disease. Suppressor activity and immune capacity.
Davidsen B; Kristensen E
Acta Med Scand; 1986; 219(1):113-24. PubMed ID: 2937257
[TBL] [Abstract][Full Text] [Related]
32. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of suppressor-cell activity by cyclophosphamide in patients with malignant melanoma.
Livingston PO; Cunningham-Rundles S; Marfleet G; Gnecco C; Wong GY; Schiffman G; Enker WE; Hoffman MK
J Biol Response Mod; 1987 Aug; 6(4):392-403. PubMed ID: 2957470
[TBL] [Abstract][Full Text] [Related]
34. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
[TBL] [Abstract][Full Text] [Related]
35. Reduced serum levels of a soluble form of the human adhesion receptor CD58 (LFA-3) in patients with inflammatory bowel disease.
Hoffmann JC; Göke MN; Evers J; Räuker HJ; Bayer B; Manns MP
Z Gastroenterol; 1996 Sep; 34(9):522-7. PubMed ID: 8873455
[TBL] [Abstract][Full Text] [Related]
36. Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.
Holdstock G; Chastenay BF; Krawitt EL
Clin Exp Immunol; 1982 Jun; 48(3):619-24. PubMed ID: 6126286
[TBL] [Abstract][Full Text] [Related]
37. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease.
Probert CS; Chott A; Turner JR; Saubermann LJ; Stevens AC; Bodinaku K; Elson CO; Balk SP; Blumberg RS
J Immunol; 1996 Oct; 157(7):3183-91. PubMed ID: 8816432
[TBL] [Abstract][Full Text] [Related]
38. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
[TBL] [Abstract][Full Text] [Related]
39. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
[TBL] [Abstract][Full Text] [Related]
40. Expression of 4C8 antigen, a novel transendothelial migration-associated molecule on activated T lymphocytes, in inflammatory bowel disease.
Oshitani N; Hato F; Kitagawa S; Masuyama J; Higuchi K; Matsumoto T; Arakawa T
J Pathol; 2002 Aug; 197(5):589-94. PubMed ID: 12210077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
